Overview

The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism

Status:
Unknown status
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
we propose that bromocriptine may be an alternative treatment of primary aldosteronism, both APA and BAH.
Phase:
Phase 4
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Bromocriptine